Product overview

Name MOG (35-55)
Purity >95%
Description Myelin oligodendrocyte glycoprotein fragment. Induces experimental multiple sclerosis-like disease.
Write Your Own Review
You're reviewing:MOG (35-55)
Rate this item:

Biological Data

Biological description

Myelin oligodendrocyte glycoprotein fragment which is a component of CNS myelin. Induces experimental multiple sclerosis-like disease and induces T-cell mediated multiple sclerosis models. Also induces tolerogenic dendritic cells and supresses disease development in multiple sclerosis models when co-administered with ITE.

Solubility & Handling

Solubility overview Soluble in water (1 mg/ml)
Storage instructions -20°C
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >95%
Molecular Weight 2581.97
Molecular Formula C118H177N35O29S
CAS Number 149635-73-4
PubChem identifier 24868190
Source Synthetic
InChiKey JMTCEFUSRHYJBF-DDJPMISGSA-N
Appearance White solid

References for MOG (35-55)

References are publications that support the biological activity of the product
  • Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

    Haas J et al (2005) European journal of immunology 35 : 3343-52
  • Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.

    Oliver AR et al (2003) Journal of immunology (Baltimore, Md. : 1950) 171 : 462-8

2 Item(s)